Achalasia. Nat Rev Dis Primers 2022;8:29.

Vaezi MF, Pandolfino JE, Yadlapati RH, et al. ACG Clinical Guidelines: diagnosis and management of achalasia. Am J Gastroenterol. 2020;115:1393–411.

Article  PubMed  PubMed Central  Google Scholar 

Becker J, Haas SL, Mokrowiecka A, et al. The HLA-DQβ1 insertion is a strong achalasia risk factor and displays a geospatial north-south gradient among Europeans. Eur J Hum Genet. 2016;24:1228–31.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vackova Z, Niebisch S, Triantafyllou T, et al. First genotype-phenotype study reveals HLA-DQβ1 insertion heterogeneity in high-resolution manometry achalasia subtypes. United Eur Gastroenterol J. 2019;7:45–51.

Article  CAS  Google Scholar 

Robertson CS, Martin BA, Atkinson M. Varicella-zoster virus DNA in the oesophageal myenteric plexus in achalasia. Gut. 1993;34:299–302.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Castagliuolo I, Brun P, Costantini M, et al. Esophageal achalasia: is the herpes simplex virus really innocent? J Gastrointest Surg. 2004;8:24–30.

Article  PubMed  Google Scholar 

Boeckxstaens GE. Achalasia: virus-induced euthanasia of neurons? Am J Gastroenterol. 2008;103:1610–2.

Article  PubMed  Google Scholar 

Wu XY, Liu ZQ, Wang Y, et al. The etiology of achalasia: an immune-dominant disease. J Dig Dis. 2021;22:126–35.

Article  CAS  PubMed  Google Scholar 

Goldblum JR, Rice TW, Richter JE. Histopathologic features in esophagomyotomy specimens from patients with achalasia. Gastroenterology. 1996;111:648–54.

Article  CAS  PubMed  Google Scholar 

Villanacci V, Annese V, Cuttitta A, et al. An immunohistochemical study of the myenteric plexus in idiopathic achalasia. J Clin Gastroenterol. 2010;44:407–10.

Article  CAS  PubMed  Google Scholar 

Liu ZQ, Dai H, Yao L, et al. A single-cell transcriptional landscape of immune cells shows disease-specific changes of T cell and macrophage populations in human achalasia. Nat Commun. 2023;14:4685.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Im SK, Yeo M, Lee KJ. Proteomic identification of proteins suggestive of immune-mediated response or neuronal degeneration in serum of achalasia patients. Gut Liver. 2013;7:411–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ma LY, Liu ZQ, Chen WF, et al. A cross-sectional study reveals a chronic low-grade inflammation in achalasia. J Gastroenterol Hepatol. 2023;38:598–608.

Article  CAS  PubMed  Google Scholar 

Jia X, Chen S, Hou X, et al. Development and validation of serum markers as noninvasive diagnostic methods for achalasia. Clin Transl Gastroenterol. 2024;15: e00651.

Article  PubMed  Google Scholar 

Clayton S, Cauble E, Kumar A, et al. Plasma levels of TNF-α, IL-6, IFN-γ, IL-12, IL-17, IL-22, and IL-23 in achalasia, eosinophilic esophagitis (EoE), and gastroesophageal reflux disease (GERD). BMC Gastroenterol. 2019;19:28.

Article  PubMed  PubMed Central  Google Scholar 

Sekula P, Del Greco MF, Pattaro C, et al. Mendelian randomization as an approach to assess causality using observational data. J Am Soc Nephrol. 2016;27:3253–65.

Article  PubMed  PubMed Central  Google Scholar 

Yeung CHC, Schooling CM. Systemic inflammatory regulators and risk of Alzheimer’s disease: a bidirectional Mendelian-randomization study. Int J Epidemiol. 2021;50:829–40.

Article  PubMed  Google Scholar 

Chen J, Xu F, Ruan X, et al. Therapeutic targets for inflammatory bowel disease: proteome-wide Mendelian randomization and colocalization analyses. EBioMedicine. 2023;89: 104494.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sun J, Zhao J, Jiang F, et al. Identification of novel protein biomarkers and drug targets for colorectal cancer by integrating human plasma proteome with genome. Genome Med. 2023;15:75.

Article  PubMed  PubMed Central  Google Scholar 

Bouras E, Karhunen V, Gill D, et al. Circulating inflammatory cytokines and risk of five cancers: a Mendelian randomization analysis. BMC Med. 2022;20:3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bilsborrow JB, Doherty E, Tilstam PV, et al. Macrophage migration inhibitory factor (MIF) as a therapeutic target for rheumatoid arthritis and systemic lupus erythematosus. Expert Opin Ther Targets. 2019;23:733–44.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huber AK, Giles DA, Segal BM, et al. An emerging role for eotaxins in neurodegenerative disease. Clin Immunol. 2018;189:29–33.

Article  CAS  PubMed  Google Scholar 

Kobayashi Y, Chu HH, Kanda A, et al. CCL4 functions as a biomarker of Type 2 airway inflammation. Biomedicines. 2022;10:1779.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Roldán V, Marín F, Lip GY, et al. Soluble E-selectin in cardiovascular disease and its risk factors. A review of the literature. Thromb Haemost. 2003;90:1007–20.

Article  PubMed  Google Scholar 

Wu GS. TRAIL as a target in anti-cancer therapy. Cancer Lett. 2009;285:1–5.

Article  CAS  PubMed  Google Scholar 

Cantarella G, Uberti D, Carsana T, et al. Neutralization of TRAIL death pathway protects human neuronal cell line from beta-amyloid toxicity. Cell Death Differ. 2003;10:134–41.

Article  CAS  PubMed  Google Scholar 

Cantarella G, Di Benedetto G, Scollo M, et al. Neutralization of tumor necrosis factor-related apoptosis-inducing ligand reduces spinal cord injury damage in mice. Neuropsychopharmacology. 2010;35:1302–14.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cantarella G, Pignataro G, Di Benedetto G, et al. Ischemic tolerance modulates TRAIL expression and its receptors and generates a neuroprotected phenotype. Cell Death Dis. 2014;5: e1331.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Björk E, Israelsson P, Nagaev I, et al. Endometriotic tissue-derived exosomes downregulate NKG2D-mediated cytotoxicity and promote apoptosis: mechanisms for survival of ectopic endometrial tissue in endometriosis. J Immunol. 2024;213(5):567–76.

Article  PubMed  PubMed Central  Google Scholar 

Loeuillard EJ, Li B, Stumpf HE, et al. Noncanonical TRAIL signaling promotes myeloid-derived suppressor cell abundance and tumor growth in cholangiocarcinoma. Cell Mol Gastroenterol Hepatol. 2024;17(5):853–76.

Article  CAS  PubMed  PubMed Central  Google Scholar 

King D, Thomas T, Chandan JS, et al. Achalasia Is associated with atopy in patients younger than 40 years of age. Am J Gastroenterol. 2021;116:416–9.

Article  PubMed  Google Scholar 

Reddy CA, Allen-Brady K, Uchida AM, et al. Achalasia is strongly associated with eosinophilic esophagitis and other allergic disorders. Clin Gastroenterol Hepatol. 2024;22:34-41.e2.

Article  CAS